Over the past few decades, treatments for malignancies in children, adolescents, and young adults (CAYA) have...

Nuclear medicine consists of imaging which displays the functional information of various organs and tissues, and...

A time is coming when chemotherapy will no longer be used to treat chronic lymphocytic leukaemia...

The 19th annual European Association for Haemophilia and Allied Disorders (EAHAD) Congress took place in Dublin...

This educational module explores the critical role of imaging in lung cancer screening, with a particular...

The Annual Conference of the Chronic Lymphocytic Leukaemia (CLL) Alliance 2026, hosted by the Haematology Association...

The pre-planned interim analysis of the Monumental-3 trial suggests the anti-GPRC5D bispecific antibody talquetamab...

Blinatumomab (BLI), inotuzumab ozogamicin (INO), and CAR T cell therapy have reshaped the treatment of relapsed/refractory...

The CD3×CD20 bispecific antibody (bsAb), epcoritamab, is approved as monotherapy for R/R diffuse large Bcell lymphoma...

Triplet therapy with azacitidine (AZA), venetoclax (VEN), and the FLT3 inhibitor gilteritinib (GILT) induces a high...

Artificial intelligence (AI) is increasingly part of the conversation about the future of breast screening. The...

PET-guided brentuximab vedotin, etoposide, cyclophosphamide, adrip/doxorubicin, dacarbazine, and dexamethasone (BrECADD) is an effective...